CompanyGraph
Safilo Group S.p.A.
SFL · Borsa Italiana · Italy
Price data from its 0NJ5 listing on LSE
safilogroup.comFinancials as of FY2025
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- ScaleRevenue is $1.1B, above the global median of $548.88M
- FinancialsAltman Z-Score 3.14: safe zone
- Interpretations2 currently firing — 2
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
749.82MEUR861.24M · vs all stocks (USD)
Trailing P/E
14.43xvs Medical Instruments & Supplies peers
Revenue (TTM)
957.72MEUR1.10B · vs all stocks (USD)
Profit Margin
5.36%vs Medical Instruments & Supplies peers
Beta
0.9880xvs all stocks
52-Week Change
7.98%vs all stocks
Market Capitalization
749.82MEUR861.24M · vs all stocks (USD)
Enterprise Value
726.35MEUR834.28M · vs all stocks (USD)
Trailing P/E
14.43xvs Medical Instruments & Supplies peers
Forward P/E
12.47xvs Medical Instruments & Supplies peers
Price to Sales (TTM)
0.7044xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
1.52xvs Medical Instruments & Supplies peers
Enterprise to Revenue
0.7580xvs Medical Instruments & Supplies peers
Enterprise to EBITDA
8.08xvs Medical Instruments & Supplies peers
Profit Margin
5.36%vs Medical Instruments & Supplies peers
Operating Margin
9.29%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
5.32%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
11.46%vs Medical Instruments & Supplies peers
Revenue (TTM)
957.72MEUR1.10B · vs all stocks (USD)
Revenue per Share (TTM)
2.31EURUpdated Sep 20, 2026Quarterly Revenue Growth
-4.80%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
595.84MEUR684.37M · vs all stocks (USD)
EBITDA (TTM)
95.53MEUR109.72M · vs all stocks (USD)
Net Income (TTM)
51.37MEUR59.00M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
6.50%vs Medical Instruments & Supplies peers
Operating Cash Flow (TTM)
127.80MEUR146.78M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
93.52MEUR107.41M · vs all stocks (USD)
Payout Ratio
0.00%vs Medical Instruments & Supplies peers
Minority Interest (Equity)
10.60MEURFY2025 · Dec 31, 2025Revenue
983.38MEURFY2025 · Dec 31, 2025Cost of Goods Sold
384.09MEURFY2025 · Dec 31, 2025Gross Profit
599.29MEURFY2025 · Dec 31, 2025Operating Income
47.14MEUR54.15M · vs all stocks (USD)
Pre-tax Income
66.96MEURFY2025 · Dec 31, 2025Income Tax Expense
18.75MEURFY2025 · Dec 31, 2025Net Income
48.21MEURFY2025 · Dec 31, 2025EBIT
74.10MEURFY2025 · Dec 31, 2025EBITDA (Income Statement)
95.53MEURFY2025 · Dec 31, 2025Selling, General & Administrative
332.06MEURFY2025 · Dec 31, 2025Other Operating Expenses
17.00MEURFY2025 · Dec 31, 2025Non-operating Interest Income
2.00MEURFY2025 · Dec 31, 2025Non-operating Interest Expense
7.14MEURFY2025 · Dec 31, 2025EPS (Basic)
0.1170EURFY2025 · Dec 31, 2025EPS (Diluted)
0.1160EURFY2025 · Dec 31, 2025Basic Shares Outstanding
414.44MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
414.44MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
48.21MEURFY2025 · Dec 31, 2025Minority Interests (P&L)
433.00KEURFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00EURFY2025 · Dec 31, 2025Operating Cash Flow
72.14MEURFY2025 · Dec 31, 2025Free Cash Flow
64.09MEURFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
52.15MEURFY2025 · Dec 31, 2025Starting Profit (CF Statement)
48.21MEURFY2025 · Dec 31, 2025Other Non-cash Items
-6.33MEURFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
7.26MEURFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
23.00MEURFY2025 · Dec 31, 2025Capital Expenditures
-8.05MEURFY2025 · Dec 31, 2025Net Intangibles (CF)
-2.52MEURFY2025 · Dec 31, 2025Net Acquisitions
11.88MEURFY2025 · Dec 31, 2025Other Investing Activity
2.00KEURFY2025 · Dec 31, 2025Net Investing Cash Flow
3.83MEURFY2025 · Dec 31, 2025Long-term Debt Issuance
0.00EURFY2025 · Dec 31, 2025Long-term Debt Payments
-30.00MEURFY2025 · Dec 31, 2025Common Stock Repurchase
-18.00MEURFY2025 · Dec 31, 2025Common Dividends Paid
-286.00KEURFY2025 · Dec 31, 2025Net Financing Cash Flow
-47.60MEURFY2025 · Dec 31, 2025Shares Outstanding
392.11MSharesUpdated Sep 20, 2026Float Shares
210.13MSharesUpdated Sep 20, 2026% Held by Insiders
49.49%vs all stocks
% Held by Institutions
26.44%vs all stocks
Total Cash (MRQ)
73.68MEUR84.63M · vs all stocks (USD)
Total Cash per Share (MRQ)
0.1770EURUpdated Sep 20, 2026Total Debt (MRQ)
79.08MEUR90.84M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.1662xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
1.78xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
1.14EURUpdated Sep 20, 2026Total Assets
758.95MEUR871.72M · vs all stocks (USD)
Total Current Assets
448.32MEURFY2025 · Dec 31, 2025Total Liabilities
355.90MEURFY2025 · Dec 31, 2025Total Non-current Assets
310.63MEURFY2025 · Dec 31, 2025Total Non-current Liabilities
93.46MEURFY2025 · Dec 31, 2025Total Current Liabilities
262.44MEURFY2025 · Dec 31, 2025Cash & Cash Equivalents
52.15MEURFY2025 · Dec 31, 2025Accounts Receivable
186.61MEURFY2025 · Dec 31, 2025Inventory
171.25MEURFY2025 · Dec 31, 2025Accounts Payable
144.52MEURFY2025 · Dec 31, 2025Short-term Debt
40.61MEURFY2025 · Dec 31, 2025Other Current Liabilities
3.11MEURFY2025 · Dec 31, 2025Long-term Debt
57.66MEURFY2025 · Dec 31, 2025Other Non-current Liabilities
4.38MEURFY2025 · Dec 31, 2025Common Stock (Book)
384.91MEURFY2025 · Dec 31, 2025Retained Earnings
-20.85MEURFY2025 · Dec 31, 2025Total Shareholders' Equity
403.05MEUR462.94M · vs all stocks (USD)
52-Week Low
1.48EURUpdated Sep 20, 202652-Week High
2.28EURUpdated Sep 20, 202652-Week Change
7.98%vs all stocks
Beta
0.9880xvs all stocks
50-Day MA
1.82EURUpdated Sep 20, 2026200-Day MA
1.80EURUpdated Sep 20, 2026Avg 10-Day Volume
502.49KSharesUpdated Sep 20, 2026Avg 30-Day Volume
604.49KSharesUpdated Sep 20, 2026Diluted EPS (TTM)
0.1200EURUpdated Sep 20, 20262 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
FCF Ratios Elevated
Its free cash flow is large next to assets and equity, and more of its operating cash reaches it than in its industry.
Reads
Industry-Benchmarked Return on Capital Elevated
It earns more on its assets and its equity than its industry, and gets more sales from those assets.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 3.14: safe zoneNotable
Altman Z-Score: 3.14
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Scale
Revenue is $1.1B, above the global median of $548.88MNotable
Revenue (USD): 1,100,021,881.039Global Median: 548,883,780.48
Levered free cash flow is $107.41M, above the global median of $18.73MNotable
Levered free cash flow (USD): 107,410,825.72Global Median: 18,729,043.027
Companies that share the same coordination system — how they create, deliver, or capture value.
Dazzle Fashion Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowAttention
Silicon Integrated Systems Corp.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Zhejiang Huayuan Auto Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Zhejiang Hailide New Material Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Zhejiang Xinao Textiles Inc.
Tier 1ProductionThroughput-Bound ConversionFlow
Wuxi Huadong Heavy Machinery Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRisk
Shandong Jinjing Science & Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Sinoseal Holding Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRisk
Changchun Faway Automobile Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRisk
Gunze Limited
Tier 1ProductionThroughput-Bound ConversionFlowRisk
Companies that share active interpretations — structural patterns currently present in both stocks.
Comfort Systems USA, Inc.
2 interpretationsIndustry-Benchmarked Return on Capital ElevatedFCF Ratios Elevated
Marvelous Inc.
2 interpretationsIndustry-Benchmarked Return on Capital ElevatedFCF Ratios Elevated
Autoliv, Inc.
2 interpretationsIndustry-Benchmarked Return on Capital ElevatedFCF Ratios Elevated